Cefdinir how supplied: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cefdinir}} {{CMG}} Cefdinir capsules USP, 300 mg, size ‘0’ capsules having blue cap imprinted twice with "LUPIN" (in black ink) and purple body imprinted twic..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cefdinir}} | {{Cefdinir}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==How Supplied== | |||
Cefdinir capsules USP, 300 mg, size ‘0’ capsules having blue cap imprinted twice with "LUPIN" (in black ink) and purple body imprinted twice with "CEFDINIR" (in white ink) containing off white to creamish granular slug, are available as follows: | Cefdinir capsules USP, 300 mg, size ‘0’ capsules having blue cap imprinted twice with "LUPIN" (in black ink) and purple body imprinted twice with "CEFDINIR" (in white ink) containing off white to creamish granular slug, are available as follows: | ||
| Line 7: | Line 9: | ||
60 Capsules/Bottle NDC 68180-711-60 | 60 Capsules/Bottle NDC 68180-711-60 | ||
Store the capsules at 20°-25°C (68°-77°F); [see USP Controlled Room Temperature]. | Store the capsules at 20°-25°C (68°-77°F); [see USP Controlled Room Temperature].<ref>{{Cite web | last = |first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50739S2LBL.pdf |url =http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50739S2LBL.pdf |publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 00:55, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
How Supplied
Cefdinir capsules USP, 300 mg, size ‘0’ capsules having blue cap imprinted twice with "LUPIN" (in black ink) and purple body imprinted twice with "CEFDINIR" (in white ink) containing off white to creamish granular slug, are available as follows:
60 Capsules/Bottle NDC 68180-711-60
Store the capsules at 20°-25°C (68°-77°F); [see USP Controlled Room Temperature].[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50739S2LBL.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.